# PROFILE 1014 (NCT01154140)

> A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01154140
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Pfizer
- Conditions: Non Squamous Lung Cancer
- Interventions: treatment; treatment
- Enrollment: 343
- Primary outcome: Progression-Free Survival (PFS) Based on IRR

## Commentary we found

- Podcasts: 6
- YouTube: 2
- X threads: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=profile-1014-nct01154140

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT01154140", "email": "<work email>"}; the inbox owner confirms by the emailed link.